<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec21" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Results</div>
 <sec id="Sec22" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Chemical constitution of 
   <span class="italic">Mentha piperita</span> L. leaf essential oil
  </div>
  <p id="Par53" xmlns="http://www.w3.org/1999/xhtml">Chemical composition of MpEO was determined by GC/MS analysis. The compounds, their percentages as well as their retention indices are listed in Table 
   <a rid="Tab1" ref-type="table" href="#Tab1">1</a>. MpEO is a mixture with 26 compounds representing 98.17% of the total oil composition. The most abundant chemicals categories for MpEO are oxygenated monoterpenes (79.50%), followed by monoterpene hydrocarbons (16.23%) and sesquiterpene hydrocarbons (2.44%). The major components of MpEO are menthol (33.59%) and iso-menthone (33.00%). In lower amounts we found a variety of compounds including limonene (8.00%), piperitone (3.20%), 1,8-cineole (2.80%), linalool (2.64%), iso-pulegol (2.40%), caryophyllene (1.95%) and pulegone (1.60%).
   <div id="Tab1" class="table-wrap">
    <span class="label">Table 1</span>
    <div class="caption">
     <p>Chemical composition (%) of leaves essential oil from Tunisian 
      <span class="italic">M.piperita</span> as identified by GC/MS analysis
     </p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th>Peak</th>
       <th>Compounds</th>
       <th>Retention Time (min)</th>
       <th>Percentage (%)</th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>1</td>
       <td>α-pinene</td>
       <td>4.42</td>
       <td>1.80</td>
      </tr>
      <tr>
       <td>2</td>
       <td>β-pinene</td>
       <td>6.07</td>
       <td>0.14</td>
      </tr>
      <tr>
       <td>3</td>
       <td>Sabinene</td>
       <td>6.42</td>
       <td>0.25</td>
      </tr>
      <tr>
       <td>4</td>
       <td>Myrcene</td>
       <td>7.81</td>
       <td>1.30</td>
      </tr>
      <tr>
       <td>5</td>
       <td>Limonene</td>
       <td>8.30</td>
       <td>8.0</td>
      </tr>
      <tr>
       <td>6</td>
       <td>1,8-cineole</td>
       <td>8.48</td>
       <td>2.80</td>
      </tr>
      <tr>
       <td>7</td>
       <td>3-octanone</td>
       <td>10.13</td>
       <td>0.45</td>
      </tr>
      <tr>
       <td>8</td>
       <td>3-octanol</td>
       <td>10.41</td>
       <td>0.53</td>
      </tr>
      <tr>
       <td>9</td>
       <td>Limonene oxide</td>
       <td>13.44</td>
       <td>0.59</td>
      </tr>
      <tr>
       <td>10</td>
       <td>α-terpineol</td>
       <td>18.62</td>
       <td>0.37</td>
      </tr>
      <tr>
       <td>11</td>
       <td>Linalool</td>
       <td>15.73</td>
       <td>2.64</td>
      </tr>
      <tr>
       <td>12</td>
       <td>iso-menthone</td>
       <td>15.14</td>
       <td>33.00</td>
      </tr>
      <tr>
       <td>13</td>
       <td>Menthyl acetate</td>
       <td>16.35</td>
       <td>0.68</td>
      </tr>
      <tr>
       <td>14</td>
       <td>Iso-pulegol</td>
       <td>16.71</td>
       <td>2.40</td>
      </tr>
      <tr>
       <td>15</td>
       <td>Isomenthol</td>
       <td>17.29</td>
       <td>0.28</td>
      </tr>
      <tr>
       <td>16</td>
       <td>Neo-iso-menthol</td>
       <td>17.90</td>
       <td>0.45</td>
      </tr>
      <tr>
       <td>17</td>
       <td>Menthol</td>
       <td>18.25</td>
       <td>33.59</td>
      </tr>
      <tr>
       <td>18</td>
       <td>Pulegone</td>
       <td>18.39</td>
       <td>1.6</td>
      </tr>
      <tr>
       <td>19</td>
       <td>Neryl acetate</td>
       <td>18.45</td>
       <td>0.8</td>
      </tr>
      <tr>
       <td>20</td>
       <td>Piperitone</td>
       <td>19.09</td>
       <td>3.2</td>
      </tr>
      <tr>
       <td>21</td>
       <td>Myrtenol</td>
       <td>19.56</td>
       <td>0.55</td>
      </tr>
      <tr>
       <td>22</td>
       <td>Carveol</td>
       <td>19.99</td>
       <td>0.31</td>
      </tr>
      <tr>
       <td>23</td>
       <td>Caryophyllene</td>
       <td>17.33</td>
       <td>1.95</td>
      </tr>
      <tr>
       <td>24</td>
       <td>Caryophyllene oxide</td>
       <td>20.10</td>
       <td>0.11</td>
      </tr>
      <tr>
       <td>25</td>
       <td>Germacrene D</td>
       <td>20.80</td>
       <td>0.11</td>
      </tr>
      <tr>
       <td>26</td>
       <td>Δ –Cadinene</td>
       <td>21.92</td>
       <td>0.27</td>
      </tr>
      <tr>
       <td rowspan="4" colspan="2"/>
       <td>Monoterpene hydrocarbons (%)</td>
       <td>16.23</td>
      </tr>
      <tr>
       <td>Oxygenated monoterpenes (%)</td>
       <td>79.5</td>
      </tr>
      <tr>
       <td>Sesquiterpene hydrocarbons (%)</td>
       <td>2.44</td>
      </tr>
      <tr>
       <td>Total (%)</td>
       <td>98.17</td>
      </tr>
     </tbody>
    </table>
   </div>
  </p>
 </sec>
 <sec id="Sec23" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Essential oil antioxidant activity</div>
  <p id="Par54" xmlns="http://www.w3.org/1999/xhtml">The antioxidant activity of MpEO was compared to that of silymarin, a well-known antioxidant, using two different assays, namely DPPH and superoxide oxygen radicals inhibition, the results are reported in Table 
   <a rid="Tab2" ref-type="table" href="#Tab2">2</a>. DPPH showed for MpEO an IC50 value around 3 times higher than the one recorded for silymarin indicating that antioxidant activity of MpEO was lower than that of silymarin.
   <div id="Tab2" class="table-wrap">
    <span class="label">Table 2</span>
    <div class="caption">
     <p>MpEO effects and positive controls on the in vitro free radical(DPPH and superoxide)</p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th/>
       <th>MpEO</th>
       <th>Silymarin</th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>50% scavenging concentration (μg/ml) on DPPH radical</td>
       <td>61.28 ± 0.02*</td>
       <td>21.25 ± 0.13</td>
      </tr>
      <tr>
       <td>50% scavenging concentration (μg/ml) on superoxide anion</td>
       <td>356.45 ± 0.35*</td>
       <td>39.04 ± 1.02</td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>Values are represented as mean ± SEM of six different experiments</p>
     <p>*
      <span class="italic">p</span> &lt; 0.05 versus silymarin
     </p>
    </div>
   </div>
  </p>
 </sec>
 <sec id="Sec24" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Serum biochemical parameters</div>
  <p id="Par55" xmlns="http://www.w3.org/1999/xhtml">The results of biochemical indicators of liver and kidney function are summarized in Tables 
   <a rid="Tab3" ref-type="table" href="#Tab3">3</a>, 
   <a rid="Tab4" ref-type="table" href="#Tab4">4</a> and 
   <a rid="Tab5" ref-type="table" href="#Tab5">5</a>. The administration of CCl
   <sub>4</sub> caused severe hepato and reno-toxicity in the treated rats, as evidenced by the significant elevations of serum ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL urea and creatinine levels, while HDL level was decreased compared to control animals.
   <div id="Tab3" class="table-wrap">
    <span class="label">Table 3</span>
    <div class="caption">
     <p>Effects of CCl
      <sub>4</sub>, MpEO and their combination MpEO/CCl
      <sub>4</sub> on hepatic markers in serum of control and experimental rats
     </p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th>Treatment and parameters</th>
       <th>AST (U/L)</th>
       <th>ALT (U/L)</th>
       <th>ALP (U/L)</th>
       <th>LDH (U/L)</th>
       <th>γ-GT (U/L)</th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>Control</td>
       <td>164.82 ± 1.28</td>
       <td>65.88 ± 1.44</td>
       <td>149.61 ± 2.19</td>
       <td>20.81 ± 0.52</td>
       <td>3.17 ± 0.39</td>
      </tr>
      <tr>
       <td>CCl
        <sub>4</sub>
       </td>
       <td>524.12 ± 5.11
        <span class="sup">***</span>
       </td>
       <td>179.23 ± 3.39
        <span class="sup">***</span>
       </td>
       <td>217.47 ± 8.55
        <span class="sup">***</span>
       </td>
       <td>40.66 ± 0.81
        <span class="sup">***</span>
       </td>
       <td>5.43 ± 0.21
        <span class="sup">***</span>
       </td>
      </tr>
      <tr>
       <td>SL/CCl
        <sub>4</sub>
       </td>
       <td>191.15 ± 2.14
        <span class="sup">###</span>
       </td>
       <td>87.82 ± 7.61
        <span class="sup">###</span>
       </td>
       <td>157.50 ± 5.12
        <span class="sup">##</span>
       </td>
       <td>28.62 ± 0.62
        <span class="sup">###</span>
       </td>
       <td>3.47 ± 0.06
        <span class="sup">###</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">a</span>/CCl
        <sub>4</sub>
       </td>
       <td>479.89 ± 36.41</td>
       <td>162.02 ± 9.18</td>
       <td>202.42 ± 7.62</td>
       <td>37.75 ± 1.35</td>
       <td>4.45 ± 0.25</td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">b</span>/CCl
        <sub>4</sub>
       </td>
       <td>356.82 ± 35.77
        <span class="sup">##</span>
       </td>
       <td>147.35 ± 5.67
        <span class="sup">##</span>
       </td>
       <td>186.74 ± 3.98
        <span class="sup">#</span>
       </td>
       <td>34.16 ± 1.35
        <span class="sup">##</span>
       </td>
       <td>4.06 ± 0.17
        <span class="sup">##</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>/CCl
        <sub>4</sub>
       </td>
       <td>216.80 ± 7.26
        <span class="sup">###</span>
       </td>
       <td>97.82 ± 6.98
        <span class="sup">###</span>
       </td>
       <td>165.96 ± 5.12
        <span class="sup">###</span>
       </td>
       <td>31.64 ± 5.12
        <span class="sup">###</span>
       </td>
       <td>3.51 ± 0.20
        <span class="sup">###</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>
       </td>
       <td>160.80 ± 2.47</td>
       <td>63.08 ± 1.16</td>
       <td>139.77 ± 7.27</td>
       <td>19.89 ± 0.18</td>
       <td>2.81 ± 0.24</td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>
      <span class="italic">AST</span> aspartate aminotransferase, 
      <span class="italic">ALT</span> alanine aminotransferase, 
      <span class="italic">ALP</span> alkaline phosphatase, 
      <span class="italic">LDH</span> lacatate dehydrogenase and 
      <span class="italic">γGT</span> gamma glutamyl transferase.
      <span class="sup">a</span>MpEO(5 mg/kg BW), 
      <span class="sup">b</span>MpEO(15 mg/kg BW), 
      <span class="sup">c</span>MpEO(40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
     </p>
     <p>Values are mean ± SEM for eight rats in each group. CCl
      <sub>4</sub>, MpEO and MpEO/CCl
      <sub>4</sub> treated groups vs control group; ** 
      <span class="italic">p</span> &lt; 0.01, *** 
      <span class="italic">p</span> &lt; 0.001, CCl
      <sub>4</sub> group vs MpEO/CCl
      <sub>4</sub> group; 
      <span class="sup">#</span>
      <span class="italic">p</span> &lt; 0.05, 
      <span class="sup"># #</span>
      <span class="italic">p</span> &lt; 0.01, 
      <span class="sup"># # #</span>
      <span class="italic">p</span> &lt; 0.001
     </p>
    </div>
   </div>
   <div id="Tab4" class="table-wrap">
    <span class="label">Table 4</span>
    <div class="caption">
     <p>Effects of CCl
      <sub>4</sub>,MpEO and their combination MpEO/CCl
      <sub>4</sub> on lipid profile in serum of control and experimental rats
     </p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th>Treatment and parameters</th>
       <th>T-Cholesterol (mmol/l)</th>
       <th>T-Triglycerides (mmol/l)</th>
       <th>HDL (mmol/L)</th>
       <th>LDL (mmol/l)</th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>Control</td>
       <td>1.133 ± 0.033</td>
       <td>0.736 ± 0.075</td>
       <td>1.413 ± 0.023</td>
       <td>0.123 ± 0.014</td>
      </tr>
      <tr>
       <td>CCl
        <sub>4</sub>
       </td>
       <td>1.750 ± 0.028
        <span class="sup">***</span>
       </td>
       <td>1.743 ± 0.078
        <span class="sup">***</span>
       </td>
       <td>0.446 ± 0.074
        <span class="sup">***</span>
       </td>
       <td>0.726 ± 0.053
        <span class="sup">***</span>
       </td>
      </tr>
      <tr>
       <td>SL/CCl
        <sub>4</sub>
       </td>
       <td>0.966 ± 0.033
        <span class="sup">###</span>
       </td>
       <td>1.043 ± 0.012
        <span class="sup">###</span>
       </td>
       <td>1.240 ± 0.030
        <span class="sup">###</span>
       </td>
       <td>0.176 ± 0.008
        <span class="sup">###</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">a</span>/CCl
        <sub>4</sub>
       </td>
       <td>1.606 ± 0.063</td>
       <td>1.610 ± 0.041</td>
       <td>0.690 ± 0.135</td>
       <td>0.640 ± 0.066</td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">b</span>/CCl
        <sub>4</sub>
       </td>
       <td>1.376 ± 0.076
        <span class="sup">##</span>
       </td>
       <td>1.196 ± 0.039
        <span class="sup">##</span>
       </td>
       <td>0.873 ± 0.053
        <span class="sup">##</span>
       </td>
       <td>0.253 ± 0.024
        <span class="sup">##</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>/CCl
        <sub>4</sub>
       </td>
       <td>1.033 ± 0.033
        <span class="sup">###</span>
       </td>
       <td>1.050 ± 0.010
        <span class="sup">###</span>
       </td>
       <td>1.296 ± 0.039
        <span class="sup">###</span>
       </td>
       <td>0.186 ± 0.017
        <span class="sup">###</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>
       </td>
       <td>1.100 ± 0.115</td>
       <td>0.763 ± 0.069</td>
       <td>1.210 ± 0.106</td>
       <td>0.113 ± 0.006</td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>
      <span class="italic">TC</span> Total cholesterol (mmol/l), 
      <span class="italic">HDL</span> high density lipoprotein (mmol/l), 
      <span class="italic">TG</span> triglyceride (mmol/l) and 
      <span class="italic">LDL</span> low density lipoprotein (mmol/l). 
      <span class="sup">a</span>MpEO (5 mg/kg BW), 
      <span class="sup">b</span>MpEO (15 mg/kg BW), 
      <span class="sup">c</span>MpEO (40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
     </p>
     <p>Values are mean ± SEM for eight rats in each group. CCl4, MpEO and MpEO/CCl
      <sub>4</sub> treated groups vs control group; ** 
      <span class="italic">p</span> &lt; 0.01, *** 
      <span class="italic">p</span> &lt; 0.001, CCl
      <sub>4</sub> group vs MpEO/CCl
      <sub>4</sub> group; 
      <span class="sup">#</span>
      <span class="italic">p</span> &lt; 0.05, 
      <span class="sup"># #</span>
      <span class="italic">p</span> &lt; 0.01, 
      <span class="sup"># # #</span>
      <span class="italic">p</span> &lt; 0.001
     </p>
    </div>
   </div>
   <div id="Tab5" class="table-wrap">
    <span class="label">Table 5</span>
    <div class="caption">
     <p>Effects of CCl
      <sub>4</sub>, MpEO and their combination MpEO/CCl
      <sub>4</sub> on kidney markers in serum of control and experimental rats
     </p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th>Treatment</th>
       <th>Urea
        <span class="break"/>(mmol/l)
       </th>
       <th>Creatinine
        <span class="break"/>(μmol /l)
       </th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>Control</td>
       <td>7.53 ± 0.59</td>
       <td>11.12 ± 0.30</td>
      </tr>
      <tr>
       <td>CCl
        <sub>4</sub>
       </td>
       <td>15.41 ± 1.57**</td>
       <td>12.79 ± 0.15**</td>
      </tr>
      <tr>
       <td>SL/CCl
        <sub>4</sub>
       </td>
       <td>8.04 ± 0.32
        <span class="sup"># #</span>
       </td>
       <td>11.19 ± 0.27
        <span class="sup"># #</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">a</span>/CCl
        <sub>4</sub>
       </td>
       <td>12.52 ± 0.32</td>
       <td>11.94 ± 0.47</td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">b</span>/CCl
        <sub>4</sub>
       </td>
       <td>10.50 ± 0.29
        <span class="sup">#</span>
       </td>
       <td>11.45 ± 0.40
        <span class="sup">#</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>/CCl
        <sub>4</sub>
       </td>
       <td>9.44 ± 0.67
        <span class="sup"># #</span>
       </td>
       <td>11.39 ± 0.30
        <span class="sup"># #</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>
       </td>
       <td>7.34 ± 0.38</td>
       <td>11.27 ± 0.35</td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>
      <span class="sup">a</span>MpEO(5 mg/kg BW), 
      <span class="sup">b</span>MpEO(15 mg/kg BW), 
      <span class="sup">c</span>MpEO(40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
     </p>
     <p>Values are mean ± SEM for ten rats in each group. CCl4, MpEO and MpEO/CCl
      <sub>4</sub> treated groups vs control group; ** 
      <span class="italic">p</span> &lt; 0.01, *** 
      <span class="italic">p</span> &lt; 0.001, CCl
      <sub>4</sub> group vs MpEO/CCl
      <sub>4</sub>group; 
      <span class="sup">#</span>
      <span class="italic">p</span> &lt; 0.05, 
      <span class="sup"># #</span>
      <span class="italic">p</span> &lt; 0.01, 
      <span class="sup"># # #</span>
      <span class="italic">p</span> &lt; 0.001
     </p>
    </div>
   </div>
  </p>
  <p id="Par56" xmlns="http://www.w3.org/1999/xhtml">Pretreatment with the MpEO at doses of 15 or 40 mg/kg significantly reduced levels of ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL urea and creatinine and increased the level of HDL compared to the CCl
   <sub>4</sub> group. It is worth noting that the treatment with 5 mg/kg MpEO did not induce any significant changes in the biochemical parameters (ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL, urea, creatinine or HDL) when compared to the CCl
   <sub>4</sub> group. Treatment of rats with only MpEO (40 mg/kg BW) did not result in significant alterations in biochemical parameters compared to control rats.
  </p>
  <p id="Par57" xmlns="http://www.w3.org/1999/xhtml">Pretreatment with silymarin (50 mg/kg), used as positive control, significantly decreased the elevated levels of ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL urea and creatinine and increased of HDL level as compared to CCl
   <sub>4</sub> group. Its effect was comparable in reducing of liver and kidney damage induced by CCl
   <sub>4</sub> with that observed for the highest dose of MpEO (40 mg/kg).
  </p>
 </sec>
 <sec id="Sec25" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Effects on lipid peroxidation</div>
  <p id="Par58" xmlns="http://www.w3.org/1999/xhtml">TBARS level is widely used as a marker for free radical mediated lipid peroxidation injury. We determined TBARS levels in the liver and kidney tissues of the investigated animals and our results are shown in Fig. 
   <a rid="Fig1" ref-type="fig" href="#Fig1">1a, b</a>. The levels of TBARS were significantly increased in both liver and kidney tissues of CCl
   <sub>4</sub>-treated animals when compared to control untreated rats.
   <div id="Fig1" class="fig">
    <span class="label">Fig. 1</span>
    <div class="caption">
     <p>
      <span class="bold">a</span> Effects of CCl
      <sub>4</sub>, MpEO and their combinations MpEO/CCl
      <sub>4</sub> on hepatic TBARS of control (Con) and experimental rats. Con, control group; mod, CCl
      <sub>4</sub>-model group
      <sub>;</sub> SL/CCl
      <sub>4</sub>, silymarin 50 mg/kg + CCl
      <sub>4</sub>; MpEO/CCl
      <sub>4</sub> 5 mg/kg + CCl
      <sub>4</sub> group; MpEO/CCl
      <sub>4</sub> 15 mg/kg + CCl
      <sub>4</sub> group; MpEO/CCl
      <sub>4</sub> 40 mg/kg + CCl
      <sub>4</sub> group; MpEO 40 mg/kg group. Values are mean ± SEM for ten rats in each group. CCl
      <sub>4</sub>, MpEO, MpEO/CCl
      <sub>4</sub> treated groups vs control group; *
      <span class="italic">p</span> &lt; 0.05, **
      <span class="italic">p</span> &lt; 0.01, *** 
      <span class="italic">p</span> &lt; 0.001, CCl
      <sub>4</sub> group vs (MpEO/CCl
      <sub>4</sub>) group; #
      <span class="italic">p</span> &lt; 0.05, ##
      <span class="italic">p</span> &lt; 0.01, ###
      <span class="italic">p</span> &lt; 0.001. 
      <span class="bold">b</span>. Effects of CCl
      <sub>4</sub>, MpEO and their combinations 
      <span class="strike">(</span>MpEO/CCl
      <sub>4</sub>
      <span class="strike">)</span> on kidney TBARS of control (Con) and experimental rats. Con, control group; mod, CCl4-model group
      <sub>;</sub> SL/CCl
      <sub>4</sub>, silymarin 50 mg/kg + CCl
      <sub>4</sub>; MpEO/CCl
      <sub>4</sub> 5 mg/kg + CCl
      <sub>4</sub> group; MpEO/CCl
      <sub>4</sub> 15 mg/kg + CCl4 group; MpEO/CCl
      <sub>4</sub> 40 mg/kg + CCl4 group; MpEO 40 mg/kg. Values are mean ± SEM for ten rats in each group. CCl
      <sub>4</sub>, MpEO, MpEO/CCl
      <sub>4</sub> treated groups vs control group; *
      <span class="italic">p</span> &lt; 0.05, **
      <span class="italic">p</span> &lt; 0.01, *** 
      <span class="italic">p</span> &lt; 0.001, CCl
      <sub>4</sub> group vs (MpEO/CCl
      <sub>4</sub>) group; #
      <span class="italic">p</span> &lt; 0.05, ##
      <span class="italic">p</span> &lt; 0.01, ###
      <span class="italic">p</span> &lt; 0.001
     </p>
    </div>
    <div xlink:href="12944_2017_645_Fig1_HTML" id="MO1" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
  </p>
  <p id="Par59" xmlns="http://www.w3.org/1999/xhtml">Pre-treatment with the MpEO at doses of 15 and 40 mg/kg BW significantly reduced levels of TBARS in liver and kidney tissues as compared to CCl
   <sub>4</sub> group. There was a dose effect; treatment with MpEO at 5 mg/kg BW did not induce any significant decrease in the levels of TBARS in liver and kidney as compared to CCl
   <sub>4</sub> group. When rats were treated with only MpEO (40 mg/kg BW), no significant differences in the TBARS values was observed compared to control rat. Pretreatment with silymarin (50 mg/kg) significantly decreased the elevated levels of TBARS in both liver and kidney compared to CCl
   <sub>4</sub> control. Moreover, the effect of silymarin (50 mg/kg) in attenuation of TBARS levels in liver and kidney was comparable with highest dose of MpEO (40 mg/kg).
  </p>
 </sec>
 <sec id="Sec26" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Effects on antioxidant enzymes</div>
  <p id="Par60" xmlns="http://www.w3.org/1999/xhtml">Results presented in Tables 
   <a rid="Tab6" ref-type="table" href="#Tab6">6</a> and 
   <a rid="Tab7" ref-type="table" href="#Tab7">7</a> showed a significant decrease in the levels of CAT, SOD, GPx in liver and kidney in CCl
   <sub>4</sub>-treated group when compared to control group. The decrease in hepatic and kidney CAT, SOD and GPx levels induced by CCl
   <sub>4</sub> injection were significantly restored (elevated) in the MpEO and silymarin groups, and this effect was more pronounced with the increase of essential oil concentration. Pretreatment with MpEO at doses of 15 and 40 mg/kg significantly increased levels of hepatic and kidney CAT, SOD and GPx as compared to CCl
   <sub>4</sub> group. It is worth noting that the treatment with MpEO at a dose 5 mg/kg did not induce any significant increase in the levels of hepatic and kidney CAT, SOD and GPx as compared to CCl
   <sub>4</sub> group. No significant differences in the values were observed in rats treated with MpEO only (40 mg/kg) compared to control rat values. Moreover, the effect of silymarin (50 mg/kg) was comparable in attenuation of levels of hepatic and kidney CAT, SOD and GPx with highest dose of MpEO (40 mg/kg).
   <div id="Tab6" class="table-wrap">
    <span class="label">Table 6</span>
    <div class="caption">
     <p>Effects of CCl
      <sub>4</sub>, MpEO and their combination MpEO/CCl
      <sub>4</sub> on the activities of enzymatic antioxidants in liver of control and experimental rats
     </p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th>Treatment</th>
       <th>SOD
        <span class="break"/>(Units/mg protein)
       </th>
       <th>CAT
        <span class="break"/>(μmol H
        <sub>2</sub>O
        <sub>2</sub>/min/mg protein)
       </th>
       <th>GPx
        <span class="break"/>(μmol GSH/min/mg protein)
       </th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>Control</td>
       <td>16.04 ± 0.11</td>
       <td>14.03 ± 0.29</td>
       <td>7.66 ± 0.51</td>
      </tr>
      <tr>
       <td>CCl
        <sub>4</sub>
       </td>
       <td>13.60 ± 0.50
        <span class="sup">***</span>
       </td>
       <td>11.13 ± 0.37
        <span class="sup">***</span>
       </td>
       <td>5.25 ± 0.25
        <span class="sup">**</span>
       </td>
      </tr>
      <tr>
       <td>SL/CCl
        <sub>4</sub>
       </td>
       <td>15.80 ± 0.50
        <span class="sup">##</span>
       </td>
       <td>13.48 ± 0.25
        <span class="sup">###</span>
       </td>
       <td>7.41 ± 0.16
        <span class="sup">###</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">a</span>/CCl
        <sub>4</sub>
       </td>
       <td>13.92 ± 0.40</td>
       <td>11.34 ± 0.41</td>
       <td>5.41 ± 0.31</td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">b</span>/CCl
        <sub>4</sub>
       </td>
       <td>14.98 ± 0.19
        <span class="sup">#</span>
       </td>
       <td>12.32 ± 0.32
        <span class="sup">#</span>
       </td>
       <td>6.04 ± 0.17
        <span class="sup">#</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>/CCl
        <sub>4</sub>
       </td>
       <td>15.65 ± 0.44
        <span class="sup">##</span>
       </td>
       <td>13.20 ± 0.19
        <span class="sup">###</span>
       </td>
       <td>7.26 ± 0.22
        <span class="sup">###</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>
       </td>
       <td>15.83 ± 0.31</td>
       <td>13.85 ± 0.33</td>
       <td>7.45 ± 0.33</td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>
      <span class="sup">a</span>MpEO(5 mg/kg BW), 
      <span class="sup">b</span>MpEO (15 mg/kg BW), 
      <span class="sup">c</span>MpEO(40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
     </p>
     <p>Values are mean ± SEM for ten rats in each group. CCl4, MpEO and MpEO/CCl
      <sub>4</sub> treated groups vs control group; ** 
      <span class="italic">p</span> &lt; 0.01, *** 
      <span class="italic">p</span> &lt; 0.001, CCl
      <sub>4</sub> group vs MpEO/CCl
      <sub>4</sub> group; 
      <span class="sup">#</span>
      <span class="italic">p</span> &lt; 0.05, 
      <span class="sup"># #</span>
      <span class="italic">p</span> &lt; 0.01, 
      <span class="sup"># # #</span>
      <span class="italic">p</span> &lt; 0.001
     </p>
    </div>
   </div>
   <div id="Tab7" class="table-wrap">
    <span class="label">Table 7</span>
    <div class="caption">
     <p>Effects of CCl
      <sub>4</sub>, MpEO and their combination MpEO/CCl
      <sub>4</sub> on the activities of enzymatic antioxidants in kidney of control and experimental rats
     </p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th>Treatment</th>
       <th>SOD
        <span class="break"/>(Units/mg protein)
       </th>
       <th>CAT
        <span class="break"/>(μmol H
        <sub>2</sub>O
        <sub>2</sub>/min/mg protein)
       </th>
       <th>GPx
        <span class="break"/>(μmol GSH/min/mg protein)
       </th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>Control</td>
       <td>15.13 ± 0.22</td>
       <td>12.90 ± 0.15</td>
       <td>5.68 ± 0.27</td>
      </tr>
      <tr>
       <td>CCl
        <sub>4</sub>
       </td>
       <td>12.12 ± 0.50
        <span class="sup">***</span>
       </td>
       <td>10.05 ± 0.34
        <span class="sup">***</span>
       </td>
       <td>4.06 ± 0.28
        <span class="sup">**</span>
       </td>
      </tr>
      <tr>
       <td>SL/CCl
        <sub>4</sub>
       </td>
       <td>14.52 ± 0.35
        <span class="sup">##</span>
       </td>
       <td>12.23 ± 0.24
        <span class="sup">###</span>
       </td>
       <td>5.56 ± 0.14
        <span class="sup">##</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">a</span>/CCl
        <sub>4</sub>
       </td>
       <td>12.92 ± 0.20</td>
       <td>10.80 ± 0.22</td>
       <td>4.46 ± 0.33</td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">b</span>/CCl
        <sub>4</sub>
       </td>
       <td>13.69 ± 0.10
        <span class="sup">#</span>
       </td>
       <td>11.02 ± 0.22
        <span class="sup">#</span>
       </td>
       <td>5.10 ± 0.28
        <span class="sup">#</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>/CCl
        <sub>4</sub>
       </td>
       <td>14.20 ± 0.35
        <span class="sup">##</span>
       </td>
       <td>12.04 ± 0.19
        <span class="sup">###</span>
       </td>
       <td>5.32 ± 0.06
        <span class="sup">##</span>
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>
       </td>
       <td>14.91 ± 0.21</td>
       <td>12.62 ± 0.33</td>
       <td>5.59 ± 0.27</td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>
      <span class="sup">a</span>MpEO(5 mg/kg BW), 
      <span class="sup">b</span>MpEO(15 mg/kg BW), 
      <span class="sup">c</span>MpEO(40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
     </p>
     <p>Values are mean ± SEM for ten rats in each group. CCl4, MpEO and MpEO/CCl
      <sub>4</sub> treated groups vs control group; ** 
      <span class="italic">p</span> &lt; 0.01, *** 
      <span class="italic">p</span> &lt; 0.001, CCl
      <sub>4</sub> group vs MpEO/CCl
      <sub>4</sub> group; 
      <span class="sup">#</span>
      <span class="italic">p</span> &lt; 0.05, 
      <span class="sup"># #</span>
      <span class="italic">p</span> &lt; 0.01, 
      <span class="sup"># # #</span>
      <span class="italic">p</span> &lt; 0.001
     </p>
    </div>
   </div>
  </p>
 </sec>
 <sec id="Sec27" class="sec">
  <div class="title" xmlns="http://www.w3.org/1999/xhtml">Histopathological findings</div>
  <p id="Par61" xmlns="http://www.w3.org/1999/xhtml">The normal liver architecture was observed in liver histology of control group (Fig. 
   <a rid="Fig2" ref-type="fig" href="#Fig2">2a</a>). Large numbers of inflammatory cells such as lymphocytes together with hepatic sinusoidal inflammation, hepatocyte necrosis and devastating liver architecture were observed in the CCl
   <sub>4</sub> group (Fig. 
   <a rid="Fig2" ref-type="fig" href="#Fig2">2b</a>). However, pretreatment with MpEO (40 mg/kg, Fig. 
   <a rid="Fig2" ref-type="fig" href="#Fig2">2f</a>) can remarkably ameliorate the histopathological hepatic lesions induced by administration of CCl
   <sub>4</sub>. MpEO 15 mg/kg showed very few inflammatory cells along with prominent nucleolus (Fig. 
   <a rid="Fig2" ref-type="fig" href="#Fig2">2e</a>). The highest dose of MpEO (40 mg/kg) and silymarin (50 mg/kg) significantly attenuated the damaged liver depicting marked focal regenerative changes which are illustrated by presence of actively dividing cells with a prominent nucleolus (Fig. 
   <a rid="Fig2" ref-type="fig" href="#Fig2">2f</a>). In addition, silymarin at the dose of 50 mg/kg has shown to produce hepatoprotection evidenced by area of regeneration and dark nucleus (Fig. 
   <a rid="Fig2" ref-type="fig" href="#Fig2">2c</a>). The histological pattern was almost normal in rats treated with MpEO oil alone. By analyzing the histopathological scoring attributed to the liver tissues it is possible to note that the highest dose of MpEO (40 mg/kg) or silymarin (50 mg/kg) pretreatment just conferred good protection on CCl
   <sub>4</sub>-induced liver damage (Table 
   <a rid="Tab8" ref-type="table" href="#Tab8">8</a>).
   <div id="Fig2" class="fig">
    <span class="label">Fig. 2</span>
    <div class="caption">
     <p>Effect of MpEO on CCl
      <sub>4</sub>-induced liver damage. 
      <span class="bold">a</span> Control group; (
      <span class="bold">b</span>) CCl
      <sub>4</sub>-model group showing marked inflammatory cells, necrosis and reduced lesions of necrosis; (
      <span class="bold">c</span>) Silymarin 50 mg/kg + CCl
      <sub>4</sub> group; (
      <span class="bold">d</span>) MpEO 5 mg/kg + CCl
      <sub>4</sub> group (
      <span class="bold">e</span>); MpEO 15 mg/kg + CCl
      <sub>4</sub> group; (
      <span class="bold">f</span>) MpEO 40 mg/kg + CCl
      <sub>4</sub> group; (
      <span class="bold">g</span>) MpEO 40 mg/kg group. Hematoxylin/eosin staining; magnification ×400. 
      <span xlink:href="12944_2017_645_Figa_HTML.gif" id="d29e2887" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : Marked inflammatory cells; 
      <span xlink:href="12944_2017_645_Figb_HTML.gif" id="d29e2890" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : Necrosis cells; 
      <span xlink:href="12944_2017_645_Figc_HTML.gif" id="d29e2893" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : Reduced lesions of necrosis; 
      <span xlink:href="12944_2017_645_Figd_HTML.gif" id="d29e2896" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : Regeneration area; 
      <span xlink:href="12944_2017_645_Fige_HTML.gif" id="d29e2900" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : Prominent nucleolus; 
      <span xlink:href="12944_2017_645_Figf_HTML.gif" id="d29e2903" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : Mild inflammatory cells
     </p>
    </div>
    <div xlink:href="12944_2017_645_Fig2_HTML" id="MO2" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
   <div id="Tab8" class="table-wrap">
    <span class="label">Table 8</span>
    <div class="caption">
     <p>Grades of inflammatory cells and cellular necrosis in rat liver</p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th colspan="9">Pathologic grading of inflammatory cells and cellular necrosis</th>
      </tr>
      <tr>
       <th>Groups</th>
       <th>Zero</th>
       <th>I</th>
       <th>II</th>
       <th>III</th>
       <th>IV</th>
       <th>N</th>
       <th char="×">
        <span class="italic">P</span> value vs Control
       </th>
       <th>
        <span class="italic">P</span> value vs CCl
        <sub>4</sub>
       </th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>Control</td>
       <td>10</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>–</td>
       <td/>
      </tr>
      <tr>
       <td>CCl
        <sub>4</sub>
        <span class="sup">***</span>
       </td>
       <td>0</td>
       <td>1</td>
       <td>3</td>
       <td>3</td>
       <td>3</td>
       <td>10</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
       <td>–</td>
      </tr>
      <tr>
       <td>SL/CCl
        <sub>4</sub>
        <span class="sup">###</span>
       </td>
       <td>8</td>
       <td>2</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">a</span>/CCl
        <sub>4</sub>
       </td>
       <td>0</td>
       <td>2</td>
       <td>6</td>
       <td>1</td>
       <td>1</td>
       <td>10</td>
       <td>
        <span class="italic">P</span> &lt; 0.05
       </td>
       <td>ns</td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">b</span>/CCl
        <sub>4</sub>
        <span class="sup">#</span>
       </td>
       <td>6</td>
       <td>4</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.05
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>/CCl
        <sub>4</sub>
        <span class="sup">###</span>
       </td>
       <td>7</td>
       <td>3</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>
       </td>
       <td>9</td>
       <td>1</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>
      <span class="sup">a</span>MpEO (5 mg/kg BW), 
      <span class="sup">b</span>MpEO (15 mg/kg BW), 
      <span class="sup">c</span>MpEO (40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
     </p>
    </div>
   </div>
  </p>
  <p id="Par62" xmlns="http://www.w3.org/1999/xhtml">Kidney sections of normal histological appearance (Fig. 
   <a rid="Fig3" ref-type="fig" href="#Fig3">3a</a>) and the CCl
   <sub>4</sub> control group showed some nephrotoxic lesions, as evidenced by the glomerular and tubular necrosis (Fig. 
   <a rid="Fig3" ref-type="fig" href="#Fig3">3b</a>). However, pretreatment with MpEO (40 mg/kg, Fig. 
   <a rid="Fig3" ref-type="fig" href="#Fig3">3f</a>) can remarkably ameliorate the histopathological kidney lesions induced by administration of CCl
   <sub>4</sub> (Fig. 
   <a rid="Fig3" ref-type="fig" href="#Fig3">3f</a>). In addition, silymarin at the dose of 50 mg/kg has shown to produce renoprotection evidenced by amelioration the histopathological kidney lesions induced by injection of CCl
   <sub>4</sub> (Fig. 
   <a rid="Fig3" ref-type="fig" href="#Fig3">3c</a>). The histological pattern in kidney was almost normal in rats treated with MpEO alone. By analyzing the histopathological scoring attributed to the kidney tissues it is possible to note that the highest dose of MpEO (40 mg/kg) or silymarin (50 mg/kg) pretreatment just conferred good protection on CCl
   <sub>4</sub>-induced kidney damage (Table 
   <a rid="Tab9" ref-type="table" href="#Tab9">9</a>).
   <div id="Fig3" class="fig">
    <span class="label">Fig. 3</span>
    <div class="caption">
     <p>Effect of MpEO on CCl
      <sub>4</sub>-induced kidney damage. 
      <span class="bold">a</span> Control group; (
      <span class="bold">b</span>) CCl
      <sub>4</sub>-model group showing some nephrotoxic lesions, as evidenced by the glomerular and tubular necrosis; (
      <span class="bold">c</span>) Silymarin 50 mg/kg + CCl
      <sub>4</sub> group; (
      <span class="bold">d</span>) MpEO 5 mg/kg + CCl
      <sub>4</sub> group (
      <span class="bold">e</span>); MpEO 15 mg/kg + CCl
      <sub>4</sub> group; (
      <span class="bold">f</span>) MpEO 40 mg/kg + CCl
      <sub>4</sub> group; (
      <span class="bold">g</span>) MpEO 40 mg/kg group. Hematoxylin/eosin staining; magnification ×400. 
      <span xlink:href="12944_2017_645_Figg_HTML.gif" id="d29e3293" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : glomerular necrosis; 
      <span xlink:href="12944_2017_645_Figh_HTML.gif" id="d29e3296" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/> : necrosis in epithelial cells of the proximal tubules
     </p>
    </div>
    <div xlink:href="12944_2017_645_Fig3_HTML" id="MO3" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </div>
   <div id="Tab9" class="table-wrap">
    <span class="label">Table 9</span>
    <div class="caption">
     <p>Grades of glomerular and epithelial cells of the proximal tubules necrosis in rat kidney</p>
    </div>
    <table frame="hsides" rules="groups">
     <thead>
      <tr>
       <th colspan="9">Pathologic grading of glomerular and epithelial cells of the proximal tubules necrosis</th>
      </tr>
      <tr>
       <th>Groups</th>
       <th>Zero</th>
       <th>I</th>
       <th>II</th>
       <th>III</th>
       <th>IV</th>
       <th>N</th>
       <th char="×">
        <span class="italic">P</span> value vs Control
       </th>
       <th>
        <span class="italic">P</span> value vs CCl
        <sub>4</sub>
       </th>
      </tr>
     </thead>
     <tbody>
      <tr>
       <td>Control</td>
       <td>10</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>–</td>
       <td/>
      </tr>
      <tr>
       <td>CCl
        <sub>4</sub>
        <span class="sup">***</span>
       </td>
       <td>0</td>
       <td>2</td>
       <td>2</td>
       <td>3</td>
       <td>3</td>
       <td>10</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
       <td>–</td>
      </tr>
      <tr>
       <td>SL/CCl
        <sub>4</sub>
        <span class="sup">###</span>
       </td>
       <td>8</td>
       <td>2</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">a</span>/CCl
        <sub>4</sub>
       </td>
       <td>0</td>
       <td>2</td>
       <td>5</td>
       <td>3</td>
       <td>0</td>
       <td>10</td>
       <td>
        <span class="italic">P</span> &lt; 0.05
       </td>
       <td>ns</td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">b</span>/CCl
        <sub>4</sub>
        <span class="sup">#</span>
       </td>
       <td>6</td>
       <td>4</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.05
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>/CCl
        <sub>4</sub>
        <span class="sup">###</span>
       </td>
       <td>7</td>
       <td>3</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
      </tr>
      <tr>
       <td>MpEO
        <span class="sup">c</span>
       </td>
       <td>9</td>
       <td>1</td>
       <td>0</td>
       <td>0</td>
       <td>0</td>
       <td>10</td>
       <td>ns</td>
       <td>
        <span class="italic">P</span> &lt; 0.001
       </td>
      </tr>
     </tbody>
    </table>
    <div class="table-wrap-foot">
     <p>
      <span class="sup">a</span>MpEO (5 mg/kg BW), 
      <span class="sup">b</span>MpEO (15 mg/kg BW), 
      <span class="sup">c</span>MpEO (40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
     </p>
    </div>
   </div>
  </p>
 </sec>
</sec>
